Literature DB >> 7889524

Enhanced effect of epidermal growth factor on pulmonary metastasis and in vitro invasion of rat mammary carcinoma cells.

J Hamada1, H Nagayasu, M Takayama, T Kawano, M Hosokawa, N Takeichi.   

Abstract

We examined the effects of epidermal growth factor (EGF) on metastatic and in vitro invasive capacity of weakly malignant ER-1 cells derived from a rat mammary carcinoma cell line, c-SST-2. EGF enhanced the metastatic capacity and in vitro invasiveness to reconstituted basement membrane, Matrigel, of ER-1 cells in a dose-dependent fashion. EGF-stimulated invasiveness was inhibited by anti-EGF antibody, which is able to neutralize the binding of EGF to EGF receptor, in the invasion assay system. EGF stimulated chemotactic migration toward fibronectin, laminin or newborn rat fibroblast-conditioned medium which was used as a chemoattractant in the in vitro invasion assay, but showed neither adhesion to Matrigel nor production of gelatinase and plasminogen activators. These results suggested that the increased metastatic and invasive capacity of ER-1 cells by EGF might be due to the increase in cell motility.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7889524     DOI: 10.1016/0304-3835(95)03686-q

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  7 in total

1.  EGF receptor signaling enhances in vivo invasiveness of DU-145 human prostate carcinoma cells.

Authors:  T Turner; P Chen; L J Goodly; A Wells
Journal:  Clin Exp Metastasis       Date:  1996-09       Impact factor: 5.150

Review 2.  p66Shc--a longevity redox protein in human prostate cancer progression and metastasis : p66Shc in cancer progression and metastasis.

Authors:  Mythilypriya Rajendran; Paul Thomes; Li Zhang; Suresh Veeramani; Ming-Fong Lin
Journal:  Cancer Metastasis Rev       Date:  2010-03       Impact factor: 9.264

3.  Epidermal growth factor receptor regulates MET levels and invasiveness through hypoxia-inducible factor-1alpha in non-small cell lung cancer cells.

Authors:  L Xu; M B Nilsson; P Saintigny; T Cascone; M H Herynk; Z Du; P G Nikolinakos; Y Yang; L Prudkin; D Liu; J J Lee; F M Johnson; K-K Wong; L Girard; A F Gazdar; J D Minna; J M Kurie; I I Wistuba; J V Heymach
Journal:  Oncogene       Date:  2010-02-15       Impact factor: 9.867

Review 4.  A novel role of Shc adaptor proteins in steroid hormone-regulated cancers.

Authors:  Syed Mahfuzul Alam; Mythilypriya Rajendran; Shouqiang Ouyang; Suresh Veeramani; Li Zhang; Ming-Fong Lin
Journal:  Endocr Relat Cancer       Date:  2008-11-11       Impact factor: 5.678

Review 5.  p66Shc as a switch in bringing about contrasting responses in cell growth: implications on cell proliferation and apoptosis.

Authors:  Sahar S Bhat; Deepak Anand; Firdous A Khanday
Journal:  Mol Cancer       Date:  2015-04-08       Impact factor: 27.401

6.  In vitro invasion of small-cell lung cancer cell lines correlates with expression of epidermal growth factor receptor.

Authors:  L Damstrup; B Rude Voldborg; M Spang-Thomsen; N Brünner; H Skovgaard Poulsen
Journal:  Br J Cancer       Date:  1998-09       Impact factor: 7.640

7.  Mito-tempol and dexrazoxane exhibit cardioprotective and chemotherapeutic effects through specific protein oxidation and autophagy in a syngeneic breast tumor preclinical model.

Authors:  Jennifer S Dickey; Yanira Gonzalez; Baikuntha Aryal; Steven Mog; Asako J Nakamura; Christophe E Redon; Ulrich Baxa; Elliot Rosen; Gang Cheng; Jacek Zielonka; Palak Parekh; Karen P Mason; Joy Joseph; Balaraman Kalyanaraman; William Bonner; Eugene Herman; Emily Shacter; V Ashutosh Rao
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.